Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery

SIMPLE SUMMARY: In this work, we aimed to explore the effectiveness of adjuvant therapy after trimodal therapy (neoadjuvant chemoradiotherapy and esophagectomy) in patients with thoracic esophageal squamous cell carcinoma (ESCC). Overall survival (OS) and disease-free survival (DFS) were both compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaokun, Luan, Siyuan, Yang, Yushang, Zhou, Jianfeng, Shang, Qixin, Fang, Pinhao, Xiao, Xin, Zhang, Hanlu, Yuan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367572/
https://www.ncbi.nlm.nih.gov/pubmed/35954385
http://dx.doi.org/10.3390/cancers14153721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367572/
https://www.ncbi.nlm.nih.gov/pubmed/35954385
http://dx.doi.org/10.3390/cancers14153721

Ejemplares similares